Carl Sailer serves as Executive at Acurx Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Carl Sailer has executed 4 insider transactions totaling $175.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 19, 2024 involved exercising options for 19,737 shares valued at $70.1K.
Carl Sailer currently holds 112,552 shares of Acurx Pharmaceuticals, Inc. (ACXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl Sailer has been a net buyer of ACXP stock. They have purchased $175.0K and sold $0 worth of shares.
Carl Sailer's most recent insider trade was on Jan 19, 2024, when they sold 19,737 shares at $3.55 per share.
Get notified when new Form 4 filings are submitted
| $3.80 |
| Discretionary |
| Nov 23, 2021 | ACXP | $25.0K | Purchase | 5,161 | $4.84 | Discretionary |
| Jun 29, 2021 | ACXP | $75.0K | Purchase | 12,500 | $6.00 | Discretionary |